Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Jan 31;137(2):369–386. doi: 10.1084/jem.137.2.369

HETEROGENEITY OF THE EFFECTOR CELLS IN THE CYTOTOXIC REACTION AGAINST ALLOGENEIC LYMPHOMA CELLS

James Forman 1, Sven Britton 1
PMCID: PMC2139487  PMID: 4539847

Abstract

The cytotoxic effect of spleen cells from H-2 allogeneic mice was tested in vitro against an A strain leukemia (YAC) labeled with [125I]iododeoxyuridine. After the mice were primed with tumor cells, significant and specific H-2 immunity was detected on day 3 and peak cytotoxicity was observed between 7 and 14 days after priming. Two effector cells appear to be involved in the host response, because spleens taken from mice soon after priming were not sensitive to antitheta sera and complement while those taken during the peak stages of the response showed a marked reduction in cytotoxicity after treatment. Macrophages were not involved, since removal of these cells by the carbonyl iron method did not result in any reduction in cytotoxicity. Immune serum that was capable of inducing cell-mediated cytotoxicity in normal spleen cell populations also augmented cytotoxicity of spleen cells taken from mice primed 3 days previously. However, when spleen cells were taken from mice during the peak phase of the immune response, the same serum at the same dilutions inhibited the preexisting cytotoxicity. A difference was also detected in the killing efficiencies between early and late immune cells.

Full Text

The Full Text of this article is available as a PDF (1,023.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britton S. When allogeneic mouse spleen cells are mixed in vitro the T-cells secrete a product which guides the maturation of B-cells. Scand J Immunol. 1972;1(1):89–98. doi: 10.1111/j.1365-3083.1972.tb03738.x. [DOI] [PubMed] [Google Scholar]
  2. Canty T. G., Wunderlich J. R., Fletcher F. Qualitative and quantitative studies of cytotoxic immune cells. J Immunol. 1971 Jan;106(1):200–208. [PubMed] [Google Scholar]
  3. Canty T. G., Wunderlich J. R. Quantitative in vitro assay of cytotoxic cellular immunity. J Natl Cancer Inst. 1970 Oct;45(4):761–772. [PubMed] [Google Scholar]
  4. Cerottini J. C., Nordin A. A., Brunner K. T. Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens. Nature. 1970 Dec 26;228(5278):1308–1309. doi: 10.1038/2281308a0. [DOI] [PubMed] [Google Scholar]
  5. Cohen A., Schlesinger M. Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation. 1970 Jul;10(1):130–132. doi: 10.1097/00007890-197007000-00027. [DOI] [PubMed] [Google Scholar]
  6. Denham S., Grant C. K., Hall J. G., Alexander P. The occurrence of two types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells. Transplantation. 1970 Apr;9(4):366–382. [PubMed] [Google Scholar]
  7. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  8. Ford W. L., Gowans J. L. The traffic of lymphocytes. Semin Hematol. 1969 Jan;6(1):67–83. [PubMed] [Google Scholar]
  9. Golstein P., Wigzell H., Blomgren H., Svedmyr E. A. Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med. 1972 Apr 1;135(4):890–906. doi: 10.1084/jem.135.4.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greaves M. F., Möller E. Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol. 1970 Oct;1(4):372–385. doi: 10.1016/0008-8749(70)90015-8. [DOI] [PubMed] [Google Scholar]
  11. Harding B., Pudifin D. J., Gotch F., MacLennan I. C. Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol. 1971 Jul 21;232(29):80–82. doi: 10.1038/newbio232080a0. [DOI] [PubMed] [Google Scholar]
  12. Hasek M., Skamene E., Karakoz I., Chutná J., Nouza K., Bubeník J., Sovová V., Nemec M., Jonák J. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum. Folia Biol (Praha) 1968;14(6):411–424. [PubMed] [Google Scholar]
  13. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer. 1971 Sep 15;8(2):185–191. doi: 10.1002/ijc.2910080202. [DOI] [PubMed] [Google Scholar]
  14. Hofer K. G., Hughes W. L. Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine. Radiat Res. 1971 Jul;47(1):94–101. [PubMed] [Google Scholar]
  15. Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst. 1969 Oct;43(4):763–773. [PubMed] [Google Scholar]
  16. Kinne D. W., Simmons R. L. Passive serologic transfer of allograft immunity in immunologically suppressed mice. II. Effect of graft exposure to immune serum in primary hosts. J Immunol. 1971 Mar;106(3):629–634. [PubMed] [Google Scholar]
  17. Linscott W. D. Effect of cell surface antigen density on immunological enhancement. Nature. 1970 Nov 28;228(5274):824–827. doi: 10.1038/228824a0. [DOI] [PubMed] [Google Scholar]
  18. Lonai P., Feldman M. Cooperation of lymphoid cells in an in vitro graft reaction system. The role of the thymus cell. Transplantation. 1970 Nov;10(5):372–381. doi: 10.1097/00007890-197011000-00003. [DOI] [PubMed] [Google Scholar]
  19. Lundgren G., Zukoski C. F., Möller G. Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol. 1968 Oct;3(8):817–836. [PMC free article] [PubMed] [Google Scholar]
  20. Miller J. F., Sprent J. Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol. 1971 Apr 28;230(17):267–270. doi: 10.1038/newbio230267a0. [DOI] [PubMed] [Google Scholar]
  21. Mishell R. I., Dutton R. W. Immunization of normal mouse spleen cell suspensions in vitro. Science. 1966 Aug 26;153(3739):1004–1006. doi: 10.1126/science.153.3739.1004. [DOI] [PubMed] [Google Scholar]
  22. Sjöberg O., Andersson J., Möller G. Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol. 1972 Apr;2(2):123–126. doi: 10.1002/eji.1830020206. [DOI] [PubMed] [Google Scholar]
  23. Sjöberg O., Britton S. Antigenic competition in vitro between heterologous erythrocytes. Eur J Immunol. 1972 Jun;2(3):282–288. doi: 10.1002/eji.1830020318. [DOI] [PubMed] [Google Scholar]
  24. Sprent J., Miller J. F. Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells. Cell Immunol. 1972 Mar;3(3):385–404. doi: 10.1016/0008-8749(72)90245-6. [DOI] [PubMed] [Google Scholar]
  25. Van Boxel J. A., Stobo J. D., Paul W. E., Green I. Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes. Science. 1972 Jan 14;175(4018):194–196. doi: 10.1126/science.175.4018.194. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES